Cibc Private Wealth Group, LLC Co Diagnostics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $52.7 Billion
- Q4 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,000 shares of CODX stock, worth $380. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,661
39.8%
Holding current value
$380
Previous $2,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CODX
# of Institutions
45Shares Held
5.59MCall Options Held
67.5KPut Options Held
174K-
Vanguard Group Inc Valley Forge, PA1.78MShares$675,7090.0% of portfolio
-
Private Advisory Group LLC Redmond, WA1.18MShares$449,0200.1% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny556KShares$211,1360.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$190,7690.0% of portfolio
-
Geode Capital Management, LLC Boston, MA346KShares$131,2940.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $12.8M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...